ASSESSMENT OF ANTIDIABETIC ACTIVITY OF THE TRADITIONAL INDIAN AYURVEDIC FORMULATION BRAHMI GRITHAM IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
Keywords:
Streptozotocin, Diabetes, Brahmi gritham, Blood glucose, HistopathologyAbstract
Objective: The aim of the present study was to determine the antidiabetic activity of Brahmi gritham a traditional Indian ayurvedic formulation in streptozotocin-induced diabetes in rats.
Methods: Diabetes was induced by a single intra-peritoneal injection of streptozotocin (55mg/kg body weight) in the experimental animals. The anti-hyperglycaemic potential of Brahmi gritham (500 mg/kg body weight) was studied by estimating the levels of plasma blood glucose and the levels of serum total cholesterol, triglycerides, total protein and albumin in the experimental rats. The serum renal functional (creatinine; urea; uric acid) and liver functional markers (aspartate transaminase; alanine transaminase; alkaline phosphatase) were also measured. The tested parameters were compared with those of the normal and the standard drug glibenclamide-treated rats. Histological analysis of the liver was done in order to visualize the efficacy of Brahmi gritham in preventing changes in liver histology in diabetic rats.
Results: Brahmi gritham showed significant (p<0.05) reduction in the elevated levels of plasma glucose, serum liver and renal function markers and total cholesterol. The formulation was also effective in restoring normal total protein and albumin levels in the serum of experimental rats.
Conclusion: The study revealed significant antidiabetic potential of Brahmi gritham in the experimental rats indicating its role in the effective management of diabetes.
Downloads
References
Harsh M. Textbook of Pathology. 6th ed. Jaypee publications, India; 2010. p. 818-29.
Ramachandran A, Das AK, Joshi SR, Yajnik CS, Shah S, Prasanna KKM. Current status of diabetes in india and need for novel therapeutic agents. Suppl JAPI 2010;58(7):7-9.
Michael W, Leslie O, Maree TS, Fraser BR, Katrina S, Andrew JH, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Cir 2003;12(1):44-50.
Ayodhya S, Kusum S, Anjali S. Hypoglycemic activity of different extracts of various herbal plants. Intl J Res Ayur Pharm 2010;1(1):212-24.
Sudha P, Remya R, Smita Z, Shoba B, Ammeta RK. Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid Based Complement Alternat Med 2011;23:1-10.
Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012;2(4):320-30.
Fritz R. Mode of action of streptozotocin. J Bacteriol 1971;105(2):580-8.
Szkudelski T. The mechanism of Alloxan and Streptozotocin action in β-cells of rat pancreas. Physiol Res 2001;50(6):537-46.
Jyoti SG, Harimohan C, Harisha CR, Renuka K, Vinay JS. Analytical profile of Brahmi Ghrita: A polyherbal Ayurvedic formulation. Ayu 2012;33(2):289-93.
Tirtha G, Tapan KM, Pinaki S, Deepak KD, Anindya B. Antidiabetic and In Vivo antioxidant activity of ethanolic extract of Bacopamonnieri Linn. aerial parts: a possible mechanism of action. Iran J Pharm Res 2008;7(1):61-8.
Kashmira JG, Jagruti AP. A review on Bacopamonniera: Current research and future prospects. Int J Green Pharm 2010;4(1):1-9.
David HP, Rangachari B, Harshit RS. Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats. Asian Pac J Trop Biomed 2012:21:941-6.
Chaturvedi P, Shukla S, Tripathi P, Chaurasia S, Singh SK, Tripathi YB. Comparitive study of Inularacemosa and Saussurealappa on the glucose level in albino rats. Anc Sci Life 1995;15(1):62-70.
Upadhyay OP, Ojha JK, Bajpai HS, Hathwal AK. Study of Kustha (Saussurealappa, Clarke) in ischaemic heart disease. Anc Sci Life1993;1(1-2):11-8.
Dhananjay VP, Harimohan C, Madhav SB, Jayesh RJ. Clinical efficacy of Shankhapushpiand a herbo-mineral compound in type-II diabetes. Ayu 2012;33(2):230-7.
Debjit B, Sampath KKP, Shravan P, Shweta S, Akhilesh PY, Amitsankar D. Traditional Indian herbs Convolvulus pluricaulisand its medicinal importance. J Pharmacogn Phytochem 2012;1(1):44-51.
Parul A, Bhawna S, Amreen F, Sanjay KJ. An update on Ayurvedic herb Convolvulus pluricaulis Choisy. Asian Pac J Trop Biomed 2014;4(3):245-52.
Singh V, Singh M, Shukla S, Singh S, Mansoori MdH, Kori ML. Antidiabetic effect of Flacourtiaindica in Streptozotocin induced diabetic rats. Global J Pharmacol 2011;5(3):147-52.
Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H. Characterization of new oral antidiabetic agent CS-045 studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988;37:1549-58.
Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Allah VA, et al. Induction of diabetes by streptozotocin in rats. Indian J Clin Biochem 2007;22(2):60-4.
Hui-Chen S, Li-Man H, Jan-Kan C. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2006;290:1339-46.
Subbiah R, Karuran S, Sorimuthu S. Antioxidant effect of Aloe veragel extract in Streptozotocin-induced diabetes in rats. Pharmacol Rep 2005;57:90-6.
Faiyaz A, Asna U. Antihyperglycaemic activity of ficusglomerata stem bark in streptozotocin-induced diabetic rats. Global J Pharmacol 2008;2(3):41-5.
Kumar GPS, Arulselvan P, Kumar DS, Subramanian SP. Anti-diabetic activity of fruits of terminaliachebulaon streptozotocin induced diabetic rats. J Health Sci 2006;52(3):283-91.
Sabu MS, Ramadasan K. Anti-Diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 2002;81:155-60.
Mauro A, Carla Z, Giuseppe R. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17(11):2974-84.
David HP, Rangachari B, Harshit RS. Antidiabetic activity of methanol extract of Acoruscalamus in STZ induced diabetic rats. Asian Pac J Trop Biomed 2012:941-6.
Babu V, Gangadevi T, Subramoniam A. Antidiabetic activity of ethanol extract of Cassia kleiniileaf in streptozotocin-induced diabetic rats and isolation of an active fraction and toxicity evaluation of the extract. Indian J Pharmacol 2003;35:290-6.
Prasenjit M, Joydeep D, Jyotirmoy G, Parames CS. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NF-κB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Free Rad Biomed 2010;48:1465-84.